Citations

Showing 10 of 108152 citations.

Contrast Acuity With Different Colors in Parkinson's Disease
Gupta, Harsh , Driver‐Dunckley, Erika , Mehta, Shyamal H. , Beach, Thomas G. , Adler, Charles H. , Gupta, Harsh V, Driver-Dunckley, Erika, Adler, C H , Zhang, Nan

Mayo Clinic

Movement Disorders Clinical Practice | August 6, 2019 | Volume: 6 | Issue: 8 | Pages: 672-677

10.1002/mdc3.12821 | PMID 31745477 Get It

ABSTRACTBackgroundAbnormal color vision and contrast acuity may have significant impact on daily activities.ObjectiveEvaluate color visual acuity, at high and low contrast, in Parkinson's disease (PD) and controls using an iPad application.MethodsColor visual acuity was tested with the Variable Contrast Acuity Chart (King‐Devick Test LLC, Oakbrook Terrace, IL) on an iPad 2 at 40 cms using five colors (red, green, blue, yellow, and black) at low (2.5%) and high (100%) contrast. A numerical score (0–95) was assigned based on the number of correctly identified letters.ResultsThirty‐six PD (mean ± standard deviation age 68 ± 10 years) and 36 controls (72 ± 11.2 years) were studied. PD disease duration was 6.4 ± 4.6 years; MDS‐UPDRS part II was 11.7 ± 7.0, and part III was 24.5 ± 9.9. After adjusting for age and sex, PD patients had significantly (P < 0.05) lower scores at high (100%) as well as low (2.5%) contrast for all five colors tested (red, green, blue, yellow, and black), except yellow low contrast (2.5%; P = 0.10). The largest effect size (0.88) was with yellow high contrast, and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy using a cut‐off score of 82 was 31%, 97%, 92%, 58%, and 64%, respectively. No correlation to disease duration was found.ConclusionsThis iPad application may be a simple‐to‐use biomarker for assessing color vision in PD. Further research is needed to determine disease specificity and whether there is a role in monitoring disease progression, treatment response, and identifying prodromal PD.
Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer
Shahjehan, Faisal , Kamatham, Saivaishnavi , Ritter, Ashton, Kasi, Pashtoon Murtaza , Kasi, Pashtoon Murtaza

Mayo Clinic

Clinical Case Reports | August 6, 2019 | Volume: 7 | Issue: 9 | Pages: 1729-1734

10.1002/ccr3.2333 | PMID 31534737 Get It

Abstract Doublet chemotherapies are the mainstay in the management of metastatic anal cancer. Immunotherapy has been incorporated into guidelines in a refractory setting. Treatment options remain limited with tumor progression beyond immunotherapy. Modified docetaxel, cisplatin, and fluorouracil (mDCF) chemotherapy, after progression postimmunotherapy, has shown a near‐complete response in our patient with metastatic anal cancer. This likely is secondary to the sequence of immunotherapy followed by chemotherapy that is yielding greater than historical responses.
Laser thermal ablation in epilepsy
Grewal, Sanjeet S. , Tatum, William O. , Grewal, Sanjeet

Mayo Clinic

Expert Review of Neurotherapeutics | August 6, 2019 | Volume: 19 | Issue: 12 | Pages: 1211-1218

10.1080/14737175.2019.1650642 | PMID 31385545 Get It

End-of-Life Decision-Making for ICU Patients With Limited English Proficiency: A Qualitative Study of Healthcare Team Insights
Barwise, Amelia , Nyquist, Christina A., Jaramillo, Carolina, Wilson, Michael E. , Barwise, Amelia K, Espinoza Suarez, Nataly R, Thorsteinsdottir, Bjorg , Barwise, Amelia K , Suárez, Nataly R. Espinoza , Gajic, Ognjen

Mayo Clinic

Critical Care Medicine | August 6, 2019 | Volume: 47 | Issue: 10 | Pages: 1380-1387

10.1097/ccm.0000000000003920 | PMID 31389838 Get It

Objectives: Research indicates that the increasing population of over 25 million people in the United States who have limited English proficiency experience differences in decision-making and subsequent care at end of life in the ICU when compared with the general population. The objective of this study was to assess the perceptions of healthcare team members about the factors that influence discussions and decision-making about end of life for patients and family members with limited English proficiency in the ICU. Design: Qualitative study using semistructured interviews with ICU physicians, nurses, and interpreters. Setting: Three ICUs at Mayo Clinic Rochester. Subjects: Sixteen ICU physicians, 12 ICU nurses, and 12 interpreters. Intervention: None. Measurements and Main Results: We conducted 40 semistructured interviews. We identified six key differences in end-of-life decision-making for patients with limited English proficiency compared with patients without limited English proficiency: 1) clinician communication is modified and less frequent; 2) clinician ability to assess patient and family understanding is impaired; 3) relationship building is impaired; 4) patient and family understanding of decision-making concepts (e.g., palliative care) is impaired; 5) treatment limitations are often perceived to be unacceptable due to faith-based and cultural beliefs; and 6) patient and family decision-making styles are different. Facilitators of high-quality decision-making in patients with limited English proficiency included: 1) premeeting between clinician and interpreter; 2) interpretation that communicates empathy and caring; 3) bidirectional communication of cultural perspectives; 4) interpretation that improves messaging including appropriate word choice; and 5) clinician cultural humility. Conclusions: End-of-life decision-making is significantly different for ICU patients with limited English proficiency. Participants identified several barriers and facilitators to high-quality end-of-life decision-making for ICU patients and families with limited English proficiency. Awareness of these factors can facilitate interventions to improve high-quality, compassionate, and culturally sensitive decision-making for patients and families with limited English proficiency.
The Potential of High‐Throughput DNA Sequencing of the Paranasal Sinus Microbiome in Diagnosing Odontogenic Sinusitis
Haider, Asad A. , Marino, Michael J. , Citardi, Martin J. , Luong, Amber , Haider, Asad , Yao, William C.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | August 6, 2019 | Volume: 161 | Issue: 6 | Pages: 1043-1047

10.1177/0194599819866692 | PMID 31382814 Get It

ObjectiveHigh‐throughput DNA sequencing of the paranasal sinus microbiome has potential in the diagnosis and treatment of sinusitis. The objective of this study is to evaluate the use of high‐throughput DNA sequencing to diagnose sinusitis of odontogenic origin.Study DesignCase series with chart review.SettingSingle tertiary care academic medical center.Subjects and MethodsA chart review was performed of DNA sequencing results from the sinus aspirates obtained under endoscopic visualization in 142 patients with sinusitis. The identification of any potentially pathogenic bacteria associated with oral flora in a sample was classified as a positive result for sinusitis of odontogenic etiology. The sensitivity, specificity, and predictive values of using high‐throughput DNA sequencing to diagnose sinusitis of odontogenic etiology were determined, with the patient’s computed tomography sinus scan as the reference standard. On computed tomography scans, an odontogenic source was determined by the presence of a periapical lucency perforating the schneiderian membrane.ResultsSeven of the 142 patients enrolled in this study had an odontogenic source based on computed tomography scans. Relative to this reference standard, high‐throughput DNA sequencing produced a sensitivity of 85.7% (95% CI, 42.1%‐99.6%), a specificity of 81.5% (95% CI, 73.9%‐87.6%), a positive predictive value of 19.4% (95% CI, 13.1%‐27.7%), and a negative predictive value of 99.1% (95% CI, 94.7%‐99.9%).ConclusionThis study supports the use of high‐throughput DNA sequencing in supplementing other methods of investigation for identifying an odontogenic etiology of sinusitis.
Three-Dimensional Printing: Current Use in Rhinology and Endoscopic Skull Base Surgery
Low, Christopher M. , Matsumoto, Jane S., Stokken, Janalee K., O’Brien, Erin K. , O'Brien, Erin K., O'Brien, Erin K , Morris, Jonathan M. , Price, Daniel L. , Matsumoto, Jane M., Choby, Garret

Mayo Clinic

American Journal of Rhinology & Allergy | August 5, 2019 | Volume: 33 | Issue: 6 | Pages: 770-781

10.1177/1945892419866319 | PMID 31382761 Get It

Background In the discipline of rhinology and endoscopic skull base surgery (ESBS), 3-dimensional (3D) printing has found meaningful application in areas including preoperative surgical planning as well as in surgical education. However, its scope of use may be limited due to the perception among surgeons that there exists a prohibitively high initial investment in resources and time to acquire the requisite technical expertise. Nevertheless, given the ever decreasing cost of advancing technology coupled with the need to understand the complex spatial relationships of the paranasal sinuses and skull base, the use of 3D printing in rhinology and ESBS is poised to blossom. Objective Help the reader identify current or potential future uses of 3D printing technology relevant to their rhinologic clinical or educational practice. Methods A review of published literature relating to 3D printing in rhinology and ESBS was performed. Results Results were reviewed and organized into 5 overarching categories including an overview of the 3D printing process as well as applications of 3D printing including (1) surgical planning, (2) custom prosthetics and implants, (3) patient education, and (4) surgical teaching and assessment. Conclusion In the discipline of rhinology and ESBS, 3D printing finds use in the areas of presurgical planning, patient education, prosthesis creation, and trainee education. As this technology moves forward, these products will be more broadly available to providers in the clinical and educational setting. The possible applications are vast and have great potential to positively impact surgical training, patient satisfaction, and most importantly, patient outcomes.
Clinical Fingerprinting: A Way to Address the Complexity and Heterogeneity of Bronchiectasis in Practice
Martínez‐García, Miguel Ángel , Aksamit, Timothy R. , Agusti, Alvar

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | August 5, 2019 | Volume: 201 | Issue: 1 | Pages: 14-19

10.1164/rccm.201903-0604pp | PMID 31381866 Get It

Does Internal Fixation for Unstable Osteochondritis Dissecans of the Skeletally Mature Knee Work? A Systematic Review
Leland, Devin P. , Bernard, Christopher D. , Camp, Christopher L. , Saris, Daniël B.F. , Krych, Aaron J. , Camp, Christopher L. , Krych, Aaron J , Nakamura, Norimasa

Mayo Clinic

Arthroscopy | August 5, 2019 | Volume: 35 | Issue: 8 | Pages: 2512-2522

10.1016/j.arthro.2019.03.020 | PMID 31395194 Get It

Purpose To report the rate of radiographic union, patient‐reported outcomes, complications, and reoperations after internal fixation of unstable osteochondritis dissecans (OCD) in the skeletally mature knee. Methods A literature search was conducted according to Preferred Reporting Items for Systematic Reviews and Meta‐Analysis guidelines. Patients were included if they were skeletally mature and underwent internal fixation of an unstable OCD lesion of the knee. Risk of bias assessment was performed using the Methodological Index for Non‐randomized Studies scoring system. Surgical technique, rate of union, patient‐reported outcomes, complications, and reoperations were collected. Results Thirteen studies resulted in 148 patients (150 knees) for inclusion. Patient age ranged from 14 to 45 years. Numerous fixation procedures were used, including biodegradable devices (rods, pins, nails, and screws), metal screws, Kirschner wire, and autologous bone sticks. Overall, reported outcome measures were heterogeneous in nature. The rate of radiographic healing ranged from 67% to 100% across 6 studies. Improved subjective results and Hughston criteria on final follow‐up ranged from 83% to 100% across 4 studies each. Mean postoperative Lysholm scores ranged from 42 to 98 in studies that reported them. Both complication and reoperation rates ranged from 0% to 44%. The most commonly performed reoperations were loose body excision and cartilage resurfacing procedures. Conclusions A variety of surgical techniques are available for treatment of unstable OCD lesions in the skeletally mature knee. In this systematic review, internal fixation of the native fragment showed acceptable rates of radiographic union and improved patient‐reported outcomes relative to other techniques. Level of Evidence Level IV, systematic review of level III‐IV studies.
Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians
Kim, Hyung‐Kwan , Lee, Sang‐Chol , Park, Jun‐Bean , Kim, Yong‐Jin , Ommen, Steve R. , Kim, Hyung-Kwan , Ommen, Steve, Choi, You‐Jung , Moon, Inki , Park, Jiesuck , Sohn, Dae‐Won

Mayo Clinic

Heart | August 5, 2019 | Volume: 105 | Issue: 24 | Pages: 1892-1897

10.1136/heartjnl-2019-315160 | PMID 31383719 Get It

Objective The hypertrophic cardiomyopathy (HCM) risk-sudden cardiac death (SCD) calculator endorsed by the 2014 European Society of Cardiology has not been independently validated in the Asians. We aimed to investigate whether the HCM Risk-SCD calculator effectively predicts SCD in Korean HCM population. Methods An observational, longitudinal cohort study was performed in 730 patients with HCM from 2007 to 2017. The primary endpoint was a composite of SCD and appropriate implantable cardioverter-defibrillator (ICD) therapy. Results During a follow-up period of 4288 person-years, 16 (2.2%) patients reached the primary endpoint. This validation study revealed a calibration slope of 0.892 and C-statistics of 0.718. The primary endpoint occurred in 1.1% (7/615), 4.6% (3/65) and 12.0% (6/50) of low-risk, intermediate-risk and high-risk groups, respectively. Although most patients (85.2%) without the primary endpoint were classified into the low-risk group, 7 of 11 SCD (63.6%) occurred in the low-risk group. In univariable and multivariable analysis, sex (woman) was significantly associated with the primary endpoint and emerged as independent predictor. The addition of sex to the HCM Risk-SCD calculator significantly improved the predictive value of the primary endpoint (net reclassification improvement 0.557, p=0.015). Conclusions In the Korean HCM population, the HCM Risk-SCD calculator had a high negative predictive value and accuracy for predicting SCD or appropriate ICD therapy, but misclassified a few patients experiencing the primary endpoint as low-risk or intermediate-risk groups.